Decibel Therapeutics Inc., of Boston, said data published in Cell showed how researchers used massively parallel single-cell RNA-sequencing to profile the transcriptomes of thousands of individual cochlear neurons and identified groups of genes (ion channels, adhesion molecules, transcription factors) that are enriched within each subtype of neuron and which may regulate their unique functional properties.